Article
Alzheimer's disease as an innate autoimmune disease (AD2): A new molecular paradigm
27 Sept 2022
Abstract excerpt
Abstract A new model of Alzheimer's disease (AD) is presented: Alzheimer's disease as an autoimmune disease (AD2). In response to pathogen‐/damage‐associated molecular pattern‐stimulating events (e.g., infection, trauma, ischemia, pollution), amyloid beta (Aβ) is released as an early responder cytokine triggering an innate immunity cascade in which Aβ exhibits immunomodulatory/antimicrobial duality. However, Aβ’s...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
